Screening for emotional distress in cancer patients: A systematic review of assessment Instruments

Journal of the National Cancer Institute

Volumn 101, Issue 21, 2009, Pages 1464-1488

  Vodermaier, Andrea ^a,b   Linden, Wolfgang ^a,c   Siu, Christopher ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF MUNICH   (Germany)

^c BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIETY; BECK DEPRESSION INVENTORY; CANCER PATIENT; CANCER SCREENING; DEPRESSION; EMOTIONAL STRESS; HUMAN; MEDLINE; MOTIVATION; PALLIATIVE THERAPY; PRIORITY JOURNAL; PSYCHOMETRY; PSYCINFO; QUESTIONNAIRE; RELIABILITY; REVIEW; SENSITIVITY AND SPECIFICITY; SOCIAL PSYCHOLOGY; SYSTEMATIC REVIEW; VALIDATION PROCESS; VALIDATION STUDY;

ADJUSTMENT DISORDERS; ANXIETY DISORDERS; DEPRESSION; DEPRESSIVE DISORDER, MAJOR; DYSTHYMIC DISORDER; HUMANS; MASS SCREENING; NEOPLASMS; PSYCHOMETRICS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; STRESS, PSYCHOLOGICAL;

EID: 70449371473     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djp336     Document Type: Review

References (156)

1. van't Spijker A, Trijsburg RW, Duivenvoorden HJ. Psychological sequelae of cancer diagnosis: a meta-analytical review of 58 studies after 1980. Psychosom Med. 1997; 59 ( 3 ): 280-293.
2. Trijsburg RW, van Knippenberg FC, Rijpma SE. Effects of psychological treatment on cancer patients: a critical review. Psychosom Med. 1992; 54 ( 4 ): 489-517.
3. Redd WH, Montgomery GH, DuHamel KN. Behavioral intervention for cancer treatment side effects. J Natl Cancer Inst. 2001; 93 ( 11 ): 810-823.
4. Osborn RL, Demoncada AC, Feuerstein M. Psychosocial interventions for depression, anxiety, and quality of life in cancer survivors: meta-analyses. Int J Psychiatry Med. 2006; 36 ( 1 ): 13-34.
5. Fawzy FI, Fawzy NW, Arndt LA, Pasnau RO. Critical review of psycho-social interventions in cancer care. Arch Gen Psychiatry. 1995; 52 ( 2 ): 100-113.
6. Meyer TJ, Mark MM. Effects of psychosocial interventions with adult cancer patients: a meta-analysis of randomized experiments. Health Psychol. 1995; 14 ( 2 ): 101-108.
7. Antoni MH, Lehman JM, Klibourn KM, et al. Cognitive-behavioral stress management intervention decreases the prevalence of depression and enhances benefi t fi nding among women under treatment for early-stage breast cancer. Health Psychol. 2001; 20 ( 1 ): 20-32.
8. Classen C, Butler LD, Koopman C, et al. Supportive-expressive group therapy and distress in patients with metastatic breast cancer: a randomized clinical intervention trial. Arch Gen Psychiatry. 2001; 58 ( 5 ): 494-501.
9. Goodwin PJ, Leszcz M, Ennis M, et al. The effect of group psychosocial support on survival in metastatic breast cancer. N Engl J Med. 2001; 345 ( 24 ): 1719-1726.
10. Sheard T, Maguire P. The effect of psychological interventions on anxiety and depression in cancer patients: results of two meta-analyses. Br J Cancer. 1999; 80 ( 11 ): 1770-1780.
11. Söllner W, DeVries A, Steixner E, et al. How successful are oncologists in identifying patient distress, perceived social support, and need for psycho-social counselling? Br J Cancer. 2001; 84 ( 2 ): 179-185.
12. Litofsky N, Scott MD, Farace E, et al. Glioma Outcomes Project Investigators. Depression in patients with high-grade glioma: results of the Glioma Outcomes Project. Neurosurgery. 2004; 54 ( 2 ): 358-367.
13. Pirl WF, Muriel A, Hwang V, et al. Screening for psychosocial distress: a national survey of oncologists. J Support Oncol. 2007; 5 ( 10 ): 499-504.
14. Mitchell AJ, Kaar S, Coggan C, Herdman J. Acceptability of common screening methods used to detect distress and related mood disorders-preferences of cancer specialists and non-specialists. Psychooncology. 2008; 17 ( 3 ): 226-236.
15. Vodermaier A, Linden W. Emotional distress screening in Canadian cancer care: a pan-national survey of utilization, tool choices and practice patterns. Oncol Exch. 2008; 7 ( 4 ): 37-40.
16. Mitchell AJ. Pooled results from 38 analyses of the accuracy of distress thermometer and other ultra-short methods of detecting cancer-related mood disorders. J Clin Oncol. 2007; 25 ( 29 ): 4670-4681.
17. Mallett S, Deeks JJ, Halligan S, Hopewell S, Cornelius V, Altman DG. Systematic reviews of diagnostic tests in cancer: review of methods and reporting. BMJ. 2006; 333 ( 7565 ): 413.
18. Kline P. The Handbook of Psychological Testing. London: Routledge; 1993.
19. Aiken LR. Psychological Testing and Assessment. 6th ed. Boston, MA: Allyn & Bacon; 1988.
20. Helgeson VS, Snyder P, Seltman H. Psychological and physical adjustment to breast cancer over 4 years: identifying distinct trajectories of change. Health Psychol. 2004; 23 ( 1 ): 3-15.
21. Teunissen SC, de Graeff A, Voest EE, de Haes JC. Are anxiety and depressed mood related to physical symptom burden? A study in hospitalized advanced cancer patients. Palliat Med. 2007; 21 ( 4 ): 341-346.
22. Jefford M, Mileshkin L, Richards K, et al. Rapid screening for depression-validation of the Brief Case-Find for Depression (BCD) in medical oncology and palliative care patients. Br J Cancer. 2004; 91 ( 5 ): 900-906.
23. Chochinov HM, Wilson KG, Enns M, Lander S. "Are you depressed?" Screening for depression in the terminally ill. Am J Psychiatry. 1997; 1 ( 5 ): 674-676.
24. Lloyd-Williams M, Dennis M, Taylor F, Baker I. Is asking patients in palliative care, "are you depressed?" appropriate? Prospective study. BMJ. 2003; 327 ( 7411 ): 372-373.
25. Lloyd-Williams M, Dennis M, Taylor F. A prospective study to determine the association between physical symptoms and depression in patients with advanced cancer. Palliat Med. 2004; 18 ( 6 ): 558-563.
26. Akechi T, Okuyama T, Sugawara Y, Shima Y, Furukawa TA, Uchitomi Y. Screening for depression in terminally ill cancer patients in Japan. J Pain Symptom Manage. 2006; 31 ( 1 ): 5-12.
27. Kawase E, Karasawa K, Shimotsu S, et al. Evaluation of a one-question interview for depression in a radiation oncology department in Japan. Gen Hosp Psychiatry. 2006; 28 ( 4 ): 321-322.
28. Payne A, Barry S, Creedon B, et al. Sensitivity and specifi city of a two-question screening tool for depression in a specialist palliative care unit. Palliat Med. 2007; 21 ( 3 ): 193-198.
29. Akizuki N, Akechi T, Nakanishi T, et al. Development of a brief screening interview for adjustment disorders and major depression in patients with cancer. Cancer. 2003; 97 ( 10 ): 2605-2613.
30. Trask PC, Paterson A, Riba M, et al. Assessment of psychological distress in prospective bone marrow transplant patients. Bone Marrow Transplant. 2002; 29 ( 11 ): 917-925.
31. Hoffman BM, Zevon MA, D'Arrigo MC, Cecchini TB. Screening for distress in cancer patients: the NCCN rapid-screening measure. Psychooncology. 2004; 13 ( 11 ): 792-799.
32. Akizuki N, Yamawaki S, Akechi T, Nakano T, Uchitomi Y. Development of an impact thermometer for use in combination with the distress thermometer as a brief screening tool for adjustment disorders and/or major depression in cancer patients. J Pain Symptom Manage. 2005; 29 ( 1 ): 91-99.
33. Gil F, Grassi L, Travado L, Tomamichel M, Gonzalez JR. Southern European Psycho-Oncology Study Group. Use of distress and depression thermometers to measure psychosocial morbidity among southern European cancer patients. Support Care Cancer. 2005; 13 ( 8 ): 600-606.
34. Jacobsen PB, Donovan KA, Trask PC, et al. Screening for psychologic distress in ambulatory cancer patients. Cancer. 2005; 103 ( 7 ): 1494-1502.
35. Ransom S, Jacobsen PB, Booth-Jones M. Validation of the distress thermometer with bone marrow transplant patients. Psychooncology. 2006; 15 ( 7 ): 604-612.
36. Ozalp E, Cankurtaran ES, Soygür H, Geyik PO, Jacobsen PB. Screening for psychological distress in Turkish cancer patients. Psychooncology. 2007; 16 ( 4 ): 304-311.
37. Recklitis CJ, Licht I, Ford J, Oeffi nger K, Diller L. Screening adult survivors of childhood cancer with the distress thermometer: a comparison with the SCL-90-R. Psychooncology. 2007; 16 ( 11 ): 1046-1049.
38. Butt Z, Wagner LI, Beaumont JL, et al. Use of a single-item screening tool to detect clinically signifi cant fatigue, pain, distress, and anorexia in ambulatory cancer practice. J Pain Symptom Manage. 2008; 35 ( 1 ): 20-30.
39. Dolbeault S, Bredart A, Mignot V, et al. Screening for psychological distress in two French cancer centers: feasibility and performance of the adapted distress thermometer. Palliat Support Care. 2008; 6 ( 2 ): 107-117.
40. Gessler S, Low J, Daniells E, et al. Screening for distress in cancer patients: is the distress thermometer a valid measure in the UK and does it measure change over time? A prospective validation study. Psychooncology. 2008; 17 ( 6 ): 538-547.
41. Hegel MT, Collins ED, Kearing S, Gillock KL, Moore CP, Ahles TA. Sensitivity and specifi city of the distress thermometer for depression in newly diagnosed breast cancer patients. Psychooncology. 2008; 17 ( 6 ): 556-560.
42. Shim EJ, Shin YW, Jeon HJ, Hahm BJ. Distress and its correlates in Korean cancer patients: pilot use of the distress thermometer and the problem list. Psychooncology. 2008; 17 ( 6 ): 548-555.
43. Tuinman MA, Gazendam-Donofrio SM, Hoekstra-Weebers JE. Screening and referral for psychosocial distress in oncologic practice. Cancer. 2008; 113 ( 4 ): 870-878.
44. Vignaroli E, Pace EA, Willey J, Palmer JL, Zhang T, Bruera E. The Edmonton Symptom Assessment System as a screening tool for depression and anxiety. J Palliat Med. 2006; 9 ( 2 ): 296-303.
45. Lees N, Lloyd-Williams M. Assessing depression in palliative care patients using the visual analogue scale: a pilot study. Eur J Cancer Care. 1999; 8 ( 4 ): 220-223.
46. Payne DK, Hoffman RG, Theodoulou M, Dosik M, Massie MJ. Screening for anxiety and depression in women with breast cancer: psychiatry and medical oncology gear up for managed care. Psychosomatics. 1999; 40 ( 1 ): 64-69.
47. Onelöv E, Steineck G, Nyberg U, et al. Measuring anxiety and depression in the oncology setting using visual-digital scales. Acta Oncol. 2007; 46 ( 6 ): 810-816.
48. Sela RA. Screening for depression in palliative cancer patients attending a pain and symptom control clinic. Palliat Support Care. 2007; 5 ( 3 ): 207-217.
49. Singer S, Danker H, Dietz A, et al. Screening for mental disorders in la-ryngeal cancer patients: a comparison of 6 methods. Psychooncology. 2008; 17 ( 3 ): 280-286.
50. Love AW, Grabsch B, Clarke DM, Bloch S, Kissane DW. Screening for depression in women with metastatic breast cancer: a comparison of the Beck Depression Inventory Short Form and the Hospital Anxiety and Depression Scale. Aust N Z J Psychiatry. 2004; 38 ( 7 ): 526-531.
51. Lloyd-Williams M, Shiels C, Dowrick C. The development of the Brief Edinburgh Depression Scale (BEDS) to screen for depression in patients with advanced cancer. J Affect Disord. 2007; 99 ( 1-3 ): 259-264.
52. Zabora J, BrintzenhofeSzoc K, Jacobsen P, et al. A new psychosocial screening instrument for use with cancer patients. Psychosomatics. 2001; 42 ( 3 ): 241-246.
53. Recklitis CJ, Rodriguez P. Screening adult survivors of childhood cancer with the distress thermometer: a comparison with the SCL-90-R. Psychooncology. 2007; 16 ( 11 ): 1046-1049.
54. Hjoerleifsdottir E, Hallberg IR, Bolmsjoe IA, Gunnarsdottir ED. Distress and coping in cancer patients: feasibility of the Icelandic version of BSI 18 and the WOC-CA questionnaires. Eur J Cancer Care. 2006; 15 ( 1 ): 80-89.
55. Recklitis CJ, Parsons SK, Shih MC, Mertens A, Robison LL, Zeltzer L. Factor structure of the Brief Symptom Inventory-18 in adult survivors of childhood cancer: results from the Childhood Cancer Survivor Study. Psychol Assess. 2006; 18 ( 1 ): 22-32.
56. Hann D, Winter K, Jacobsen P. Measurement of depressive symptoms in cancer patients: evaluation of the Center for Epidemiological Studies Depression Scale (CES-D). J Psychosom Res. 1999; 46 ( 5 ): 437-443.
57. Schroevers MJ, Sanderman R, van Sonderen E, Ranchor AV. The evaluation of the Center for Epidemiologic Studies Depression (CES-D) scale: depressed and positive affect in cancer patients and healthy reference subjects. Qual Life Res. 2000; 9 ( 9 ): 1015-1029.
58. Katz MR, Kopek N, Waldron J, Devins GM, Tomlinson G. Screening for depression in head and neck cancer. Psychooncology. 2004; 13 ( 4 ): 269-280.
59. Hopko DR, Bell JL, Armento ME, et al. The phenomenology and screening of clinical depression in cancer patients. J Psychosoc Oncol. 2008; 26 ( 1 ): 31-51.
60. Lloyd-Williams M, Friedman T, Rudd N. Criterion validation of the Edinburgh Postnatal Depression Scale as a screening tool for depression in patients with advanced metastatic cancer. J Pain Symptom Manage. 2000; 20 ( 4 ): 259-265.
61. Lloyd-Williams M, Riddleston H. The stability of depression scores in patients who are receiving palliative care. J Pain Symptom Manage. 2002; 24 ( 6 ): 593-597.
62. Le Fevre P, Devereux J, Lawrie SM, Cornbleet M. Screening for psychiatric illness in the palliative care inpatient setting: a comparison between the Hospital Anxiety and Depression Scale and the General Health Questionnaire-12. Palliat Med. 1999; 13 ( 5 ): 399-407.
63. Reuter K, Haerter M. Screening for mental disorders in cancer patients-discriminant validity of HADS and GHQ-12 assessed by standardized clinical interviews. Int J Methods Psychiatr Res. 2001; 10 ( 2 ): 86-96.
64. Razavi D, Delvaux N, Farvacques C, Robaye E. Screening for adjustment disorders and major depressive disorders in cancer in-patients. Br J Psychiatry. 1990; 156 ( 1 ): 79-83.
65. Hopwood P, Howell A, Maguire P. Screening for psychiatric morbidity in patients with advanced breast cancer: validation of two self-report questionnaires. Br J Cancer. 1991; 64 ( 2 ): 353-356.
66. Moorey S, Greer S, Watson M, et al. The factor structure and factor stability of the Hospital Anxiety and Depression Scale in patients with cancer. Br J Psychiatry. 1991; 158 ( 2 ): 255-259.
67. Brandberg Y, Bolund C, Sigurdardottir V, Sjoeden PO, Sullivan M. Anxiety and depressive symptoms at different stages of malignant melanoma. Psychooncology. 1992; 1 ( 2 ): 71-78.
68. Razavi D, Delvaux N, Bredart A, et al. Screening for psychiatric disorders in a lymphoma out-patient population. Eur J Cancer. 1992; 28A ( 11 ): 1869-1872.
69. Ibbotson T, Maguire P, Selby P, Priestman T, Wallace L. Screening for anxiety and depression in cancer patients: the effects of disease and treatment. Eur J Cancer. 1994; 30A ( 1 ): 37-40.
70. Ramirez AJ, Richards MA, Jarrett SR, Fentiman IS. Can mood disorder in women with breast cancer be identifi ed preoperatively? Br J Cancer. 1995; 72 ( 6 ): 1509-1512.
71. Berard RMF, Boermeester F, Viljoen G. Depressive disorders in an outpatient oncology setting: prevalence, assessment, and management. Psychooncology. 1998; 7 ( 2 ): 112-120.
72. Kugaya A, Akechi T, Okuyama T, Okamura H, Uchitomi Y. Screening for psychological distress in Japanese cancer patients. Jpn J Clin Oncol. 1998; 28 ( 5 ): 333-338. (Pubitemid 128522959)
73. Costantini M, Musso M, Viterbori P, et al. Detecting psychological distress in cancer patients: validity of the Italian version of the Hospital Anxiety and Depression Scale. Support Care Cancer. 1999; 7 ( 3 ): 121-127.
74. Hall A, A'Hern R, Fallowfi eld L. Are we using appropriate self-report questionnaires for detecting anxiety and depression in women with early breast cancer? Eur J Cancer. 1999; 35 ( 1 ): 79-85.
75. Hosaka T, Awazu H, Aoki T, Okuyama T, Yamawaki S. Screening for adjustment disorders and major depression in otolaryngology patients using the Hospital Anxiety and Depression Scale. Int J Psychiatr Clin Pract. 1999; 3 ( 1 ): 43-48.
76. Kugaya A, Akechi T, Okuyama T, et al. Prevalence, predictive factors, and screening for psychologic distress in patients with newly diagnosed head and neck cancer. Cancer. 2000; 88 ( 12 ): 2817-2823.
77. Cull A, Gould A, House A, et al. Validating automated screening for psychological distress by means of computer touchscreens for use in routine oncology practice. Br J Cancer. 2001; 85 ( 12 ): 1842-1849.
78. Lloyd-Williams M, Friedman T, Rudd N. An analysis of the validity of the Hospital Anxiety and Depression Scale as a screening tool in patients with advanced metastatic cancer. J Pain Symptom Manage. 2001; 22 ( 6 ): 990-996.
79. Morasso G, Costantini M, Viterbori P, et al. Predicting mood disorders in breast cancer patients. Eur J Cancer. 2001; 37 ( 2 ): 216-223.
80. Love AW, Kissane DW, Bloch S, Clarke DM. Diagnostic effi ciency of the Hospital Anxiety and Depression Scale in women with early stage breast cancer. Aust N Z J Psychiatry. 2002; 36 ( 2 ): 246-250.
81. Smith AB, Selby PJ, Velikova G, et al. Factor analysis of the Hospital Anxiety and Depression Scale from a large cancer population. Psychol Psychother. 2002; 75 ( 2 ): 165-176.
82. Montazeri A, Vahdaninia M, Ebrahimi M, Jarvandi S. The Hospital Anxiety and Depression Scale (HADS): translation and validation study of the Iranian version. Health Qual Life Outcomes. 2003; 1 ( 1 ): 14.
83. Keller M, Sommerfeldt S, Fischer C, et al. Recognition of distress and psychiatric morbidity in cancer patients: a multi-method approach. Ann Oncol. 2004; 15 ( 8 ): 1243-1249.
84. Mystakidou K, Tsilika E, Parpa E, Katsouda E, Galanos A, Vlahos L. The Hospital Anxiety and Depression Scale in Greek cancer patients: psychometric analyses and applicability. Support Care Cancer. 2004; 12 ( 12 ): 821-825.
85. Osborne RH, Elsworth GR, Sprangers MA, Oort FJ, Hopper JL. The value of the Hospital Anxiety and Depression Scale (HADS) for comparing women with early onset breast cancer with population-based reference women. Qual Life Res. 2004; 13 ( 1 ): 191-206.
86. Rodgers J, Martin C, Morse R, Kendell K, Verrill M. An investigation into the psychometric properties of the Hospital Anxiety and Depression Scale in patients with breast cancer. Health Qual Life Outcomes. 2005; 3 ( 1 ): 41.
87. Thomas BC, Devi N, Sarita GP, et al. Reliability & validity of the Malayalam Hospital Anxiety & Depression Scale (HADS) in cancer patients. Indian J Med Res. 2005; 122 ( 5 ): 395-399.
88. Muszbek K, Szekely A, Balogh EM, et al. Validation of the Hungarian translation of Hospital Anxiety and Depression Scale. Qual Life Res. 2006; 15 ( 4 ): 761-766.
89. Smith AB, Wright EP, Rush R, Stark DP, Velikova G, Selby PJ. Rasch analysis of the dimensional structure of the Hospital Anxiety and Depression Scale. Psychooncology. 2006; 15 ( 9 ): 817-827.
90. Néron S, Correa JA, Dajczman E, Kasymjanova G, Kreisman H, Small D. Screening for depressive symptoms in patients with unresectable lung cancer. Support Care Cancer. 2007; 15 ( 10 ): 1207-1212.
91. Walker J, Postma K, McHugh GS, et al. Performance of the Hospital Anxiety and Depression Scale as a screening tool for major depressive disorder in cancer patients. J Psychosom Res. 2007; 63 ( 1 ): 83-91.
92. Miklavcic IV, Snoj Z, Mlakar J, Pregelj P. Validation of the Slovenian version of Hospital Anxiety and Depression Scale in female cancer patients. Psychiatr Danub. 2008; 20 ( 2 ): 148-152.
93. Özalp E, Soygür H, Cankurtaran E, Turhan L, Akbiyik D, Geyik P. Psychiatric morbidity and its screening in Turkish women with breast cancer: a comparison between the HADS and SCID tests. Psychooncology. 2008; 17 ( 7 ): 668-675.
94. Kirsh KL, McGrew JH, Dugan M, Passik SD. Diffi culties in screening for adjustment disorder, part I: use of existing screening instruments in cancer patients undergoing bone marrow transplantation. Palliat Support Care. 2004; 2 ( 1 ): 23-31.
95. Chen SC, Lai YH, Liao CT, Lin CC. Psychometric testing of the Impact of Event Scale-Chinese Version (IES-C) in oral cancer patients in Taiwan. Support Care Cancer. 2005; 13 ( 7 ): 485-492.
96. Mystakidou K, Tsilika E, Parpa E, Galanos A, Vlahos L. Psychometric properties of the Impact of Event Scale in Greek cancer patients. J Pain Symptom Manage. 2007; 33 ( 4 ): 454-461.
97. Roth AJ, Rosenfeld B, Kornblith AB, et al. The Memorial Anxiety Scale for prostate cancer. Cancer. 2003; 97 ( 11 ): 2910-2918.
98. Roth A, Nelson CJ, Rosenfeld B, et al. Assessing anxiety in men with prostate cancer: further data on the reliability and validity of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC). Psychosomatics. 2006; 47 ( 4 ): 340-347.
99. Dale W, Hemmerich J, Meltzer D. Extending the validity of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC) at the time of prostate biopsy in a racially-mixed population. Psychooncology. 2007; 16 ( 5 ): 493-498.
100. Morasso G, Costantini M, Baracco G, Borreani C, Capelli M. Assessing psychological distress in cancer patients: validation of a self-administered questionnaire. Oncology. 1996; 53 ( 4 ): 295-302.
101. Omoro SA, Fann JR, Weymuller EA, Macharia IM, Yueh B. Swahili translation and validation of the Patient Health Questionnaire-9 depression scale in the Kenyan head and neck cancer patient population. Int J Psychiatry Med. 2006; 36 ( 3 ): 367-381.
102. Fann JR, Berry DL, Wolpin S, et al. Depression screening using the Patient Health Questionnaire-9 administered on a touch screen computer. Psychooncology. 2009; 18 ( 1 ): 14-22.
103. Andrykowski MA, Cordova MJ, Studts JL, Miller TW. Posttraumatic stress disorder after treatment for breast cancer: prevalence of diagnosis and use of the PTSD Checklist-Civilian Version (PCL-C) as a screening instrument. J Consult Clin Psychol. 1998; 66 ( 3 ): 586-590.
104. Smith MY, Redd W, DuHamel K, Vickberg SJ, Ricketts P. Validation of the PTSD Checklist-Civilian Version in survivors of bone marrow transplantation. J Trauma Stress. 1999; 12 ( 3 ): 485-499.
105. DuHamel KN, Ostrof J, Ashman T, et al. Construct validity of the post-traumatic stress disorder checklist in cancer survivors: analyses based on two samples. Psychol Assess. 2004; 16 ( 3 ): 255-266.
106. Sutherland HJ, Lockwood GA, Cunningham AJ. A simple, rapid method for assessing psychological distress in cancer patients: evidence of validity for linear analog scales. J Psychosoc Oncol. 1989; 7 ( 1/2 ): 31-43.
107. Passik SD, Dugan W, McDonald MV, Rosenfeld B, Theobald DE, Edgerton S. Oncologists ' recognition of depression in their patients with cancer. J Clin Oncol. 1998; 16 ( 4 ): 1594-1600.
108. Dugan W, McDonald MV, Passi SD, Rosenfeld BD, Theobald D, Edgerton S. Use of the Zung Self-Rating Depression Scale in cancer patients: feasibility as a screening tool. Psychooncology. 1998; 7 ( 6 ): 483-493.
109. Passik SD, Lundberg JC, Rosenfeld B, et al. Factor analysis of the Zung Self-Rating Depression Scale in a large ambulatory oncology sample. Psychosomatics. 2000; 41 ( 2 ): 121-127.
110. Passik SD, Kirsh KL, Donaghy KB, et al. An attempt to employ the Zung Self-Rating Depression Scale as a "lab test" to trigger follow-up in ambulatory oncology clinics: criterion validity and detection. J Pain Symptom Manage. 2001; 21 ( 4 ): 273-281.
111. Sharpley CF, Christie DR. An analysis of the psychometric profi le and frequency of anxiety and depression in Australian men with prostate cancer. Psychooncology. 2007; 16 ( 7 ): 660-667.
112. Mystakidou K, Tsilika E, Parpa E, Smyrniotis V, Galanos A, Vlahos L. Beck Depression Inventory: exploring its psychometric properties in a palliative care population of advanced cancer patients. Eur J Cancer Care. 2007; 16 ( 3 ): 244-250.
113. Thomas BC, Mohan VN, Thomas I, Pandey M. Development of a distress inventory for cancer: preliminary results. J Postgrad Med. 2002; 48 ( 1 ): 16-20.
114. Hughson AV, Cooper AF, McArdle CS, Smith DC. Validity of the General Health Questionnaire and its subscales in patients receiving chemotherapy for early breast cancer. J Psychosom Res. 1988; 32 ( 4-5 ): 393-402.
115. Meyer HA, Sinnott C, Seed PT. Depressive symptoms in advanced cancer. Part 1. Assessing depression: the Mood Evaluation Questionnaire. Palliat Med. 2003; 17 ( 7 ): 596-603. (Pubitemid 37279340)
116. Meyer HA, Sinnott C, Seed PT. Depressive symptoms in advanced cancer. Part 2. Depression over time; the role of the palliative care professional. Palliat Med. 2003; 17 ( 7 ): 604.
117. Baker F, Denniston M, Zabora J, Polland A, Dudley WN. A POMS short form for cancer patients: psychometric and structural evaluation. Psychooncology. 2002; 11 ( 4 ): 273-281.
118. Linden W, Yi D, Barroetavena M, MacKenzie R, Doll R. Development and validation of a psychosocial screening instrument for cancer. Health Qual Life Outcomes. 2005; 3 ( 1 ): 54.
119. Linden W, Vodermaier A, McKenzie R, Barroetavena MC, Yi D, Doll R. The Psychosocial Screen for Cancer (PSSCAN): further validation and normative data. Health Qual Life Outcomes. 2009; 7 ( 1 ): 16.
120. Herschbach P, Marten-Mittag B, Henrich G. Revision und psy-chometrische Prüfung des Fragebogens zur Belastung von Krebskranken (FBK-R23). Z Med Psychol. 2003; 12 ( 2 ): 1-8.
121. Herschbach P, Keller M, Knight L, et al. Psychological problems of cancer patients: a cancer distress screening with a cancer-specifi c questionnaire. Br J Cancer. 2004; 91 ( 3 ): 504-511.
122. de Haes JC, van Knippenberg FC, Neijt JP. Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist. Br J Cancer. 1990; 62 ( 6 ): 1034-1038.
123. Paci E. Assessment of validity and clinical application of an Italian version of the Rotterdam Symptom Checklist. Qual Life Res. 1992; 1 ( 2 ): 129-134.
124. Watson M, Law M, Maguire GP, et al. Further development of a quality of life measure for cancer patients: The Rotterdam Symptom Checklist (revised). Psychooncology. 1992; 1 ( 1 ): 35-44.
125. Agra Y, Badfa X. Spanish version of the Rotterdam Symptom Check List: cross-cultural adaptation and preliminary validity in a sample of terminal cancer patients. Psychooncology. 1998; 7 ( 3 ): 229-239.
126. Tchen N, Soubeyran P, Eghbali H, et al. Quality of life in patients with aggressive non-Hodgkin's lymphoma. Validation of the medical outcomes study short form 20 and the Rotterdam Symptom Checklist in older patients. Crit Rev Oncol Hematol. 2002; 43 ( 3 ): 219-226.
127. Derogatis LR. BSI-18: Administration, Scoring and Procedures Manual. Minneapolis, MN: National Computer Systems; 2000.
128. Derogatis LR. The Brief Symptom Inventory (BSI). Administration, Scoring and Procedures Manual. 3rd ed. Minneapolis, MN: National Computer Systems; 1993.
129. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977; 1 ( 3 ): 385-401.
130. Goldberg DP, Gater R, Sartorius N, et al. The validity of two versions of the GHQ in the WHO study of mental illness in general health care. Psychol Med. 1997; 27 ( 1 ): 191-197.
131. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983; 67 ( 6 ): 361-370.
132. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001; 16 ( 9 ): 606-613.
133. Derogatis L. SCL-90-R Administration, Scoring and Practice Manual. Baltimore, MD: Clinical Psychiatric Research; 2000.
134. Spielberger DC, Gorsuch RL, Lushene RE. Manual of the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press; 1970.
135. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961; 4 ( 6 ): 561-571.
136. Roth AJ, Kornblith AB, Batel-Copel L, Peabody E, Scher HI, Holland JC. Rapid screening for psychologic distress in men with prostate carcinoma. Cancer. 1998; 82 ( 10 ): 1904-1908.
137. Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K. The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care. 1991; 7 ( 2 ): 6-9.
138. Fishman B, Pasternak S, Wallenstein SL, Houde RW, Holland JC, Foley KM. The Memorial Pain Assessment Card. A valid instrument for the evaluation of cancer pain. Cancer. 1987; 60 ( 5 ): 1151-1158.
139. Beck AT, Rial WY, Rickels K. Short form of depression inventory: cross-validation. Psychol Rep. 1974; 34 ( 3 ): 1184-1186.
140. Cox JL, Holden JM, Sagovsky R. Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry. 1987; 150 ( 6 ): 782-786.
141. Strittmatter G. Indikation zur Intervention in der Psychoonkologie. Psychosoziale Belastungen und Ermittlung der Betreuungsbedürftigkeit stationärer Hauttumorpatienten. Waxmann, Internationale Hochschulschriften 228: Münster: New York; 1997.
142. Horowitz M, Wilner N, Alvarez W. Impact of Event Scale: a measure of subjective stress. Psychosom Med. 1979; 41 ( 3 ): 209-218
143. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. text revised, Washington, DC: American Psychiatric Association; 2000.
144. Weathers FW, Ford J. Psychometric properties of the PTSD Checklist (PCL-C, PCL-S, PCL-M, PCL-PR). In: Stamm BH, eds. Measurement of Stress, Trauma, and Adaptation. Lutherville, MD: Sidran Foundation & Press; 1996: 250-252.
145. Zung WW. A self-rating depression scale. Arch Gen Psychiatry. 1965; 12 ( 1 ): 63-70.
146. Beck AT, Steer RA. Beck Anxiety Inventory Manual. San Antonio, TX: The Psychological Corporation; 1990.
147. Melvin TA, Ozbek IN, Eberle DE. Recognition of depression. Hospice J. 1995; 10 ( 3 ): 39-46.
148. Shacham S. A shortened version of the Profi le of Mood States. J Pers Assess. 1983; 47 ( 3 ): 305-306.
149. Stein KD, Denniston M, Baker F, et al. Validation of a Modifi ed Rotterdam Symptom Checklist for use with cancer patients in the United States. J Pain Symptom Manage. 2003; 26 ( 5 ): 975-989.
150. Mitchell AJ. Are one or two simple questions suffi cient to detect depression in cancer and palliative care? A Bayesian meta-analysis. Br J Cancer. 2008; 98 ( 12 ): 1934-1943.
151. Whooley MA, Avins AL, Miranda J, Browner WS. Case-fi nding instruments for depression: two questions are as good as many. J Gen Intern Med. 1997; 12 ( 7 ): 439-445.
152. Arroll B, Goodyear-Smith F, Kerse N, Fishman T, Gunn J. Effect of the addition of a "help" question to two screening questions on specifi city for diagnosis of depression in general practice: diagnostic validity study. BMJ. 2005; 331 ( 7521 ): 884.
153. Ohno T, Noguchi W, Nakayama Y, Kato S, Tsujii H, Suzuki Y. How do we interpret the answer "Neither" when physicians ask patients with cancer "Are you depressed or not?" J Palliat Med. 2006; 9 ( 4 ): 861-865.
154. Spinhoven P, Ormel J, Sloekers PP, Kempen GI, Speckens AE, Van Hemert AM. A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects. Psychol Med. 1997; 27 ( 2 ): 363-370.
155. Allenby A, Matthews J, Beresford J, McLachlan SA. The application of computer touch-screen technology in screening for psychosocial distress in an ambulatory oncology setting. Eur J Cancer Care. 2002; 11 ( 4 ): 245-253.
156. Shimizu K, Akechi T, Okamura M, et al. Usefulness of the nurse-assisted screening and psychiatric referral program. Cancer. 2005; 103 ( 9 ): 1949-1956.